Abstract:The risk of developing Alzheimer's disease (AD) is almost double in patients with insulin resistance. Prolong hyperinsulinemia is a major cause of insulin resistance. We presented in last year that peripheral hyperinsulinemia and insulin resistance alters the biology and function in neurons at early stages. Mechanistically, we showed that failure of prompt glucose metabolism due to loss of hexokinase-2 (HK2) impairs a multi-step pathway that results in reactivation of cell cycle machinery, as well as accumulation of signals of phosphorylated tau and amyloid. Despite all these cellular findings, it is important to address these series of events in vivo, and their consequences on animal behavior. Assays including behavioral analyses in young (3-month) versus aged (22-44 month) wild type mice (N=24) were performed. Stereotaxic injections of adeno-associated virus (AAV) that carries shRNA against HK2 were performed in hippocampal CA1 region of young non-insulin resistant wildtype mice. Behavioral, immunohistochemistry and a variety of cellular and biochemistry methods were performed to analyze changes occurred in these animals. Here we report that insulin resistant neurons eventually become senescent, a consequence of aberrant reactivation of cell cycle machinery. At behavioral level, insulin resistant animals showed cognitive decline and memory impairment, both were inter-correlated to the severity of peripheral insulin resistance and the senescent load in the brain. Mechanistically, the importance of neuronal glycolysis was validated in vivo. Similar behavioral changes were recapitulated in young non-insulin resistant animals with HK2 knockdown in CA1 neurons. Notably, these neurons also showed aberrant cell cycle re-activation and expressed a senescent phenotype. These findings therefore extended our understanding on how peripheral hyperinsulinemia and insulin resistance alters the biology and function of the brain, particularly at behavioral levels. At basic science level, our data also offer a mechanism on how post-mitotic neurons could become senescent—an outcome of aberrant cell cycle reactivation. At translational level, this study re-emphasizes that metabolic syndrome like peripheral insulin resistance is a modifiable risk factor for AD. Better management of insulin resistance is therefore a important strategy to prevent related neurodegeneration events and potential initiation of AD.

AMPK induced memory improvements in the diabetic population: A case study

Nutritional Ketosis and photobiomodulation remediate mitochondria warding off Alzheimer's disease in a diabetic, ApoE4+ patient with mild cognitive impairment: A case report

AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats

Carnosine-based reversal of diabetes-associated cognitive decline via activation of the Akt/mTOR pathway and modulation of autophagy in a rat model of type 2 diabetes mellitus

Metabolic syndrome marks early risk for cognitive decline with APOE4 gene variation: A case study

Ketogenic diet rescues cognition in ApoE4+ patient with mild Alzheimer's disease: A case study

The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease

Ketogenic interventions restore cognition and modulate peripheral metabolic dysfunctions in Alzheimer’s disease mouse models

INSULIN RESISTANT NEURONS ARISEN FROM PERIPHERAL HYPERINSULINEMIA ARE SENESCENT AND CORRELATE WITH MEMORY IMPAIRMENT AND COGNITIVE DECLINE: IMPLICATIONS FOR ALZHEIMER’S DISEASE

The cerebral hypometabolism model of Alzheimer's disease explored: can a ketogenic diet improve cognition in Alzheimer's disease? A review of the literature

Activated AMPK mitigates diabetes-related cognitive dysfunction by inhibiting hippocampal ferroptosis

Adenosine monophosphate activated protein kinase (AMPK) is essential for the memory improving effect of adiponectin

Highlighting the protective or degenerative role of AMPK activators in dementia experimental models.

Environmental Enrichment and Metformin Improve Metabolic Functions, Hippocampal Neuron Survival, and Hippocampal-Dependent Memory in High-Fat/High-Sucrose Diet-Induced Type 2 Diabetic Rats

Insulin resistance-induced hyperglycemia decreased the activation of Akt/CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunction

Brain Insulin Resistance Deteriorates Cognition by Altering the Topological Features of Brain Networks.

Lipoic acid improves neuronal insulin signalling and rescues cognitive function regulating VGlut1 expression in high-fat-fed rats: Implications for Alzheimer's disease

P2‐157: BRAIN‐SPECIFIC REPRESSION OF AMPKα1 ALLEVIATES MEMORY DEFICITS AND SYNAPTIC FAILURE IN A MOUSE MODEL OF ALZHEIMER'S DISEASE

A spotlight on underlying the mechanism of AMPK in diabetes complications

Evidence of metabolic memory-induced neurodegeneration and the therapeutic effects of glucagon-like peptide-1 receptor agonists via Forkhead box class O

A randomized feasibility trial of the modified Atkins diet in older adults with mild cognitive impairment due to Alzheimer's disease